Navigation Links
PRA International Expands Presence in Asia:
Date:7/15/2009

RALEIGH, N.C., July 15 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces the opening of its office in South Korea, complementing the company's extensive network of Asian operations and partnerships. South Korea is widely regarded as the third most important pharmaceutical market in Asia and one of the most important Asian countries for clinical studies to support new drug registrations. China, Japan and South Korea have made a joint statement of cooperation on clinical research and Japan is now accepting South Korean clinical trial data for Japanese registration.

The government of South Korea has demonstrated its commitment to establishing the country as a key clinical research location in the Asian region through the formation of KoNECT, the South Korea National Enterprise for Clinical Trials. The increasing volume of multinational clinical research taking place across all trial phases is indicative of the organization's success. Pharmaceutical companies are attracted to the region by its many advantages, including:

  • Quality of clinical data
  • Progressive and efficient regulatory and ethical systems, exemplified by 30-day Approval Clock for INDs and adherence to ICH-GCP
  • Active engagement of world-class Investigators
  • Highly educated and committed clinical research professionals (CRAs, Study Nurses, and Study site personnel)
  • State-of-the-art trial facilities including 124 Korean FDA accredited sites and 12 regional clinical trial centers overseen by KoNECT
  • Proximity to vast patient populations

PRA has been providing clinical trial management services in South Korea since 2005, mainly through local partnerships. "Increasing customer expectations and project needs have prompted us to establish a legal entity and a local team of clinical professionals," noted Edward Ian, Sr. Director of Clinical Operations, PRA - Asia Pacific. "We anticipate significant growth of our operations in South Korea in the next few years to conduct clinical studies across a wide array of therapeutic indications, including oncology, neurology, respiratory disorders, infectious diseases and cardiovascular, endocrinology and metabolic disorders."

PRA's Executive VP of Product Registration for Europe, Africa and Asia-Pacific, Susan Stansfield, also commented: "The addition of the South Korean office to our existing Asian network, together with our continuing plans for expansion across the Asian region, further enhances PRA International's position as a CRO gateway to the world's most dynamic and rapidly expanding clinical research environment."

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. We perform studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.

Pharmaceutical Research Associates Korea Limited is located at:

    5th Floor, Pyeonghwan Building
    1579-6 Seocho-Dong, Seocho-Gu
    Seoul, South Korea 137-875
    T: +82-2-585-8155
    F: +82-2-585-3055


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship
2. American Hygiene Habits Getting Worse: International Study Reveals More Illness-Causing Germs Than Ever in American Kitchens
3. Nu Skin Chairman Recognized With 2009 International Award for Outstanding Business Performance
4. Phonak and Hear the World Wins International Stevie Award in Sixth Annual International Business Awards
5. Medizone International, Inc. Has Filed for Patent Protection for Its AsepticSure(TM) Hospital Sterilization System
6. Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress
7. Special Olympics Minnesota Athletes Take Part in Free Vision Screening at Lions Club International Annual Convention
8. Diageos DRINKiQ.com Honored as Most Outstanding Health & Wellness Site by International Academy of the Visual Arts
9. International conference on reproductive science to be held in Pittsburgh July 18-22
10. CareFusion Corporation Launches International Jazz Festival Series
11. EnVivo to Share Results of its EVP-6124 Phase Ib/IIa Trial at The International Conference on Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... MA (PRWEB) , ... February 11, 2016 , ... The ... overpaying for IT services, what questions to ask your IT consultant before signing a ... access to your computer network. , “With companies relying heavily on e-mail and technology, ...
(Date:2/11/2016)... , ... February 11, 2016 , ... As part of ... of the Million Dollar Round Table Foundation (MDRTF), has gifted $10,000 to University of ... Colleen’s Dream Foundation President Billy Cundiff. , “We are honored to support a promising ...
(Date:2/10/2016)... City, California (PRWEB) , ... February 10, 2016 ... ... Imaging Society (WMIS), known as the World Molecular Imaging Congress (WMIC), will be ... theme for the 2016 meeting is “Imaging Biology…Improving Therapy.” The congress will highlight ...
(Date:2/10/2016)... ... 2016 , ... Early this week, Team Iconic at J. Walter Thompson and ... the first global confectionery brand sourced from 100% sustainable cocoa. , The Nestlé Cocoa ... product, through activities that focus on better farming, better lives and better cocoa. In ...
(Date:2/10/2016)... , ... February 10, 2016 ... ... Inc. , a full-service health care communications company offering education, research and ... resource for practitioners and specialists working in infectious diseases. , As the ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016 --> ... Gas), and Spectroscopy Market by Industry (Oil & Gas, Petrochemical, ... Paper, Metal & Mining, and Others), And Geography - ... market is expected to grow to USD 3.9 Billion ... 2015 and 2020. Browse 82 market data ...
(Date:2/10/2016)... -- Resolve Therapeutics, LLC, a clinical stage biopharmaceutical company ... of lupus and Sjogrens syndrome, today announced the ... in patients with systemic lupus erythematosus (SLE) with ... --> Data from a multicenter ... RSLV-132 in 32 subjects with SLE demonstrate the ...
(Date:2/10/2016)... -- Urologix, the market leader for in-office minimally invasive ... (BPH), announces new private ownership and is operating as ... industry veteran of more than 20 years, has been ... Plymouth, Minn. The company,s two ... RF Therapy, will continue to be broadly available and ...
Breaking Medicine Technology: